Medical/Pharmaceuticals
Bridge Biotherapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
SEONGNAM, South Korea and BOSTON, Dec. 30, 2024 /PRNewswire/ -- Bridge Biotherapeutics (KQ288330), a clinical-stage biotech company based in South Korea developing novel drugs for fibrosis and cancer, today announced that James Jungkue Lee, Founder and CEO of Bridge Biotherapeutics, will present ...
2024-12-30 23:00
3028
CARsgen Announces Positive Topline Results from China GC/GEJ Pivotal Phase II Clinical Trial of Claudin18.2 CAR-T (Satri-cel)
SHANGHAI, Dec. 30, 2024 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announces the positive results from the pivotal Phase II clinical trial CT041-...
2024-12-30 21:50
2963
WuXi AppTec's Commitment to Sustainability Recognized by the Dow Jones Sustainability Indices (DJSI) for the Fourth Consecutive Year
SHANGHAI, Dec. 30, 2024 /PRNewswire/ -- WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life science industries, announced that it has been recognized by the prestigious Dow Jones Sustainability Indices ...
2024-12-30 20:00
3212
Alphamab Oncology Announced Anti-HER2 Bispecific ADC JSKN003 Received Approval from CDE to Initiate a Phase III Clinical Study for Ovarian Cancer
SUZHOU, China, Dec. 27, 2024 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that anti-HER2 bispecific antibody-drug conjugate (ADC) JSKN003 has received approval from the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) to initiate a Phase...
2024-12-30 13:28
6078
Huadong Medicine Co., Ltd. and SynerK reached a strategic cooperation to jointly develop a novel siRNA drug SNK-2726
SUZHOU, China, Dec. 30, 2024 /PRNewswire/ -- Hangzhou Sino-US Huadong Medicine Co., Ltd. (hereinafter referred to as "Huadong Medicine"), a wholly-owned subsidiary of Huadong Medicine Co., Ltd. (SZ.000963), and SynerK PharmaTech (Suzhou) Co., Ltd. (hereinafter referred to as "SynerK") have reache...
2024-12-30 13:00
2156
Maypharm Unveils Revolutionary Hybrid Filler, Hyalmass Aqua-Exosome: The Future of Skin Hydration and Regeneration
* Introducing Hyaluronic Acid, Exosomes, and PDRN SEOUL, South Korea, Dec. 30, 2024 /PRNewswire/ -- Maypharm Co., Ltd., a leading innovator in medical and dermo-cosmetic products, proudly introduces the global launch of Hyalmass Aqua-Exosome, a groundbreaking hybrid mesotherapy filler designed ...
2024-12-30 13:00
3295
"Closing the Women's Health Gap - Highlights of Biotropics Malaysia clinical study by Women, on Women, for Women"
SHAH ALAM, Malaysia, Dec. 30, 2024 /PRNewswire/ -- While gender parity has seen progress in recent years, the women's health gap remains significant. Women, despite comprising half of the global labor force[1], often face under-diagnosis and under-representation in healthcare research. Biotropics...
2024-12-30 10:00
3826
Telix Files TLX250-CDx (Zircaix®) BLA for Kidney Cancer Imaging
MELBOURNE, Australia and INDIANAPOLIS, Dec. 30, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX; Nasdaq: TLX, Telix, the Company) today announces that it has submitted its Biologics License Application (BLA) tothe United States (U.S.) Food and Drug Administration (FDA) for TLX250-CDx...
2024-12-30 06:00
3070
BMG Completed Acquisition of High-Quality Assets, Marking a New Chapter in Diversified Growth
CHENGDU, China, Dec. 27, 2024 /PRNewswire/ -- BGM Group Ltd. (Nasdaq: BGM) (the "Company" or "BGM"), a leading global pharmaceutical enterprise, today announced completion of the acquisition of the intelligent platform of AIX Inc. It marks BGM's official entry into the domains of AI intelligent t...
2024-12-27 22:30
8505
Ascentage Pharma to Present at 43rd Annual J.P. Morgan Healthcare Conference
ROCKVILLE, Md. and SUZHOU, China, Dec. 27, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address global unmet medical needs primarily for malignancies, today announced that its Chairman and ...
2024-12-27 09:44
11727
VISTA Eye Specialist Revolutionizes Dry Eye Treatment with Groundbreaking Research and Advanced Technology
PETALING JAYA, Malaysia, Dec. 27, 2024 /PRNewswire/ -- VISTA Eye Specialist (VISTA),Malaysia's leading eye care provider, proudly announces a major milestone in the treatment of dry eye disease. A groundbreaking study led by Dr. Aloysius Joseph Low, Medical Director and Ms. Azarina Abdullah, Optom...
2024-12-27 08:00
3716
Microtech Announces First Human Case of Implantable Microsensor for Heart Failure
TEL AVIV, Israel, Dec. 26, 2024 /PRNewswire/ -- Microtech, a wholly owned subsidiary of Medinol Inc., a leader in global MedTech research and development, announced that it has initiated human clinical trials of their microsensor platform, in a trial to measure atrial pressures important for the ...
2024-12-26 19:00
3366
IND Application for a Phase I/II Clinical Study of Anti-HER2 Bispecific ADC Subcutaneous Co-formulation JSKN033 was Approved
SUZHOU, China, Dec. 26, 2024 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that a phase I/II clinical trial (Study ID: JSKN033-102) of JSKN033, a high-concentration subcutaneous co-formulation consisting of anti-HER2 bispecific antibody-drug conjugate (ADC) and PD-L1 immune ch...
2024-12-26 17:09
4974
Matwings Technology Raised Series A Funding of Tens of Millions USD to Redefine Protein Design
'Beyond Structure, Predicting Function' SHANGHAI, Dec. 25, 2024 /PRNewswire/ -- Recently, Shanghai Matwings Technology Co., Ltd. ('Matwings'), a global leader in AI-driven protein design, announced the successful completion of Series A funding rounds, raising tens of millions of USD, led by Qimi...
2024-12-26 11:07
2200
Haikou delivers mix of tradition and cutting-edge industry
BEIJING, Dec. 25, 2024 /PRNewswire/ -- A news report from China Daily: Haikou, capital of South China’s Hainan province, is a vibrant metropolis known for its bustling ports, golden beaches and profound culture. Join Michael and Ani on a scavenger hunt in Haikou to explore its unique charm！ F...
2024-12-26 10:07
2614
Preliminary Results of Qilu Pharmaceutical's Phase Ia Study on GPRC5D/CD3-Targeting Bispecific Antibody QLS32015 Unveiled at 2024 ASH Annual Meeting
JINAN, China, Dec. 25, 2024 /PRNewswire/ -- During the 66th Annual Meeting of the American Society of Hematology (ASH) held inSan Diego from December 7 to 10 , preliminary results from the first human trial of QLS32015, a novel anticancer drug developed by Qilu Pharmaceutical for treating relapse...
2024-12-25 15:42
3243
Industry Partnership | Basecare Medical Group (2170.HK) and Jinghua Medical Group Sign Strategic Cooperation Agreement
SUZHOU, China, Dec. 25, 2024 /PRNewswire/ -- On December 24, 2024, Basecare Medical Group (2170.HK) held a strategic cooperation signing ceremony with Jinghua Medical Group inShenyang. Basecare Medical possesses a comprehensive technological platform covering andrology, embryo culture, genetics, ...
2024-12-25 11:03
5762
European Wellness Biomedical Group Announces New Klotho Research Initiative Led by Prof. Mike Chan
HEIDELBERG, Germany, Dec. 25, 2024 /PRNewswire/ -- European Wellness Biomedical
Group (EWBG)
2024-12-25 09:00
5389
Designs For Health Inc. Held Liable For Infringement of Kaneka's Ubiquinol Patent
TOKYO, Dec. 25, 2024 /PRNewswire/ -- Kaneka has successfully defended its patent for stabilizing Ubiquinol. OnDecember 20, 2024, Kaneka Corporation won its lawsuit against Designs for Health, Inc. and AmericanRiver Nutrition, LLC for infringement of Kaneka's U.S. Patent No. 7,829,080 (the "'080 P...
2024-12-25 02:31
5275
Ractigen Therapeutics Announces First Patient Dosed in Phase I Clinical Trial for RAG-17 in SOD1-ALS
NANTONG and SUZHOU, China, Dec. 24, 2024 /PRNewswire/ -- Ractigen Therapeutics, a clinical-stage pharmaceutical company dedicated to developing RNA-based innovative therapies, today announced the successful dosing of the first patient in the Phase I clinical trial of RAG-17, an innovative siRNA t...
2024-12-24 20:00
4263
Week's Top Stories
Most Reposted
Agoda Launches Agoda Impact Lab at ASEAN Tourism Forum
[Picked up by 318 media titles]
2026-01-29 15:06
Agoda Launches Open-Source API Agent to Simplify MCP Server Integrations
[Picked up by 309 media titles]
2026-01-27 13:00
Nokia Strengthens Edge AI Capabilities Through Strategic Collaboration with Blaize on Hybrid Inference Solutions Across Asia Pacific Regions
[Picked up by 294 media titles]
2026-01-27 18:00
Multi-Award Winning Phuket Marriott Resort & Spa, Merlin Beach: Voted Top 3 Best Family Resort
[Picked up by 283 media titles]
2026-01-30 08:00
True 1000Hz Powerhouse: PHILIPS EVNIA Unleashes the World's First 1000Hz Dual-Mode Gaming Monitor 27M2N5500XD
[Picked up by 282 media titles]
2026-01-29 18:03
